Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06459115

Adherence to Medication in Patients With Acute Decompensated Heart Failure

Adherence to Medication in Patients With Acute Decompensated Heart Failure: a Cross-sectional Study at the Emergency Department (ADHF-ED= Adherence to Medication in Patients With Acute Decompensated Heart Failure at the Emergency Department)

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Universität des Saarlandes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Every day, patients present to emergency department due to acute heart failure. There are many causes for decompensation. One possible cause is a lack of adherence to heart failure medication (prognosis-improving medications and diuretics). The aim of this study is to directly measure adherence in patients with acute heart failure (gold standard of adherence measurement using liquid chromatography coupled to high-resolution mass spectrometry= LC-HRMS/MS) at the emergency department. Questionnaires are used to investigate possible factors influencing adherence.

Detailed description

Several drugs has been shown to improve survival and to reduce the risk for hospitalization for acute heart failure (AHF) in patients with chronic heart failure. Despite optimal drug treatment, patients with heart failure suffer one hospitalization for AHF every year on average with the requirement of intravenous diuretics. Hence, AHF is one of the leading causes for emergency department visits in elderly patients. A possible cause for AHF in patients with known heart failure is nonadherence to drug treatment. Long-term-adherence to drugs of chronic diseases is low. Direct methods to assess adherence like the measurement drug levels or metabolites in body fluids are considered as the gold standard. This study aimed to i) provide (direct measured) adherence rates of patients presented with AHF to the emergency department and ii) to identify patient-related factors with impact on adherence.

Conditions

Timeline

Start date
2023-02-01
Primary completion
2024-10-31
Completion
2024-12-31
First posted
2024-06-14
Last updated
2024-06-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06459115. Inclusion in this directory is not an endorsement.